V
VOR
Vor Biopharma Inc.
18.05
+0.66+3.80%After Hours: 18.27 +0.22 +1.22%19:51 04/02 EDT
OPEN/PREV CLOSE15.60/15.75
TODAY RANGE15.50-16.39
VOL316
MARKET CAP762.02M
52 WEEK RANGE2.622-65.80
AVG VOL (3M)994.92K
% TURNOVER1.92%
TURNOVER0
P/E (TTM)-0.2213
% RANGE5.65%
EPS(TTM)-70.5014
P/E(FORWARD)-5.1064
P/B-3.6761
BVPS-4.2436
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP572.53M
SHARES OUTSTANDING48.85M
NEXT EARNINGS05/12-05/18
FREE FLOAT36.70M
LOT SIZE1
EX-DATE09/19/2025
News
Press Releases
Financial Reports
Profile
Seeking Alpha·1d ago
Vor Biopharma: It's A Game Of Wait And See
Reuters·04/01 21:16
Vor Biopharma initial beneficial ownership filed by TCG Crossover GP II, LLC
Reuters·04/01 21:00
Vor Bio grants inducement equity awards to 9 new hires under Nasdaq rule
Reuters·04/01 21:00
VOR BIO REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)
Barchart·04/01 16:00
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Dow Jones·03/31 14:32
Vor Biopharma Price Target Raised to $15.00/Share From $9.00 by Wedbush
Dow Jones·03/31 14:32
Vor Biopharma Is Maintained at Neutral by Wedbush
Benzinga·03/31 14:23
Wedbush Maintains Neutral on Vor Biopharma, Raises Price Target to $15
TipRanks·03/31 11:58
Vor Bio price target raised to $15 from $9 at Wedbush
Reuters·03/31 11:27
VOR BIOPHARMA INC <VOR.O>: WEDBUSH RAISES TARGET PRICE TO $15 FROM $9
TipRanks·03/31 11:00
Wall Street Analysts Are Bullish on Top Healthcare Picks
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.